Brigatinib in NF2 -Related Schwannomatosis with Progressive Tumors.

Scott R PlotkinKaleb H YohayPhioanh L NghiemphuChristine T DinhDusica Babovic-VuksanovicVanessa L MerkerAnnette BakkerGeoffrey FellLorenzo TrippaJaishri O Blakelynull null

Published in: The New England journal of medicine (2024)

-SWN. (Funded by the Children's Tumor Foundation and others; INTUITT-NF2 ClinicalTrials.gov number, NCT04374305.).

Keyphrases

signaling pathway
lps induced
pi k akt
nuclear factor
oxidative stress
multiple sclerosis
young adults
inflammatory response
toll like receptor